YOU ARE HERE: LAT HomeCollectionsColon Cancer

Colon Cancer

May 14, 2012 | By Thomas H. Maugh II
This post has been corrected. See note at the bottom for details. A colonoscopy is a life-saving procedure, identifying polyps and early-stage tumors so they can be removed before they grow and spread. But many people refuse to undergo the procedure because they don't relish having an endoscope inserted into their body, and they don't like the preparation for the procedure, which requires drinking laxatives and spending large amounts of time in the lavatory the night before.
March 6, 2012 | By Michael A. Memoli
Rep. Donald Payne, the first African American elected to Congress from New Jersey and the dean of that state's delegation, died Tuesday after a long battle with colon cancer. He was 77. Payne represented New Jersey's heavily democratic 10th District, encompassing parts of Union, Hudson and Essex counties, including sections of Newark. He was a teacher, business executive and local officeholder before winning his seat in Congress in 1988. He was easily reelected 11 more times. Payne was chairman of the Congressional Black Caucus Foundation and had held several leadership roles in the House.
February 22, 2012 | By Eryn Brown, Los Angeles Times / For the Booster Shots blog
Colon cancer is the third deadliest cancer in the U.S.; it is expected to kill more than 51,000 Americans this year, according to the American Cancer Society. Physicians have long assumed that removing precancerous polyps during patient colonoscopies reduces the numbers of such deaths. Now researchers have proved it. In a large, multi-decade study of more than 2,600 patients who had precancerous polyps removed during colonoscopies between 1980 and 1990, scientists at the Memorial Sloan-Ketting Cancer Center in New York and colleagues at other institutions found that removing the polyps reduced deaths from colon cancer in the group by 53%.  An article detailing their results was published Wednesday in the New England Journal of Medicine.
January 10, 2012 | By David Lazarus
Here's your take-me-home-tonight Tuesday roundup of consumer news from around the Web: -- There's no sugar high for Hostess Brands, maker of the Twinkie and other fine products. The company is reportedly preparing to go back into bankruptcy just two years after completing its last bankruptcy proceedings. People familiar with the matter say the company is facing a cash crunch with more than $860 million in debt, high labor expenses and rising ingredient costs. When Hostess, then called Interstate Bakeries, filed for bankruptcy protection in 2004, it blamed low sales and high fixed costs.
October 27, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
Patients with a genetic condition that increases their risk of colon and other cancers who took aspirin daily developed colon cancer less often than patients who took a placebo, researchers reported Thursday. The study, which was the first randomized controlled trial to look at the effect of aspirin on cancer rates, was published in the journal the Lancet. Professor John Burn, a geneticist at Newcastle University in England, led the research team.  The group followed 861 people with Lynch syndrome, which increases the risk of developing colon and other cancers.  Some of the patients took two 600 mg aspirins every day, others took a placebo.
October 12, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
Ginger root supplements may help tamp down markers for colon inflammation, a study finds. The study, published online Tuesday in the journal Cancer Prevention Research , included 30 men and women who were randomly assigned to take 2 grams of a ginger root supplement or a placebo for 28 days. The participants were at normal risk for colon cancer -- they had no family history of the disease and no evidence of the disease. Ginger root is a popular supplement that's often used to treat stomach ailments.
September 27, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
In England, getting screened and treated for colorectal cancer -- the second leading cause of cancer death in the United Kingdom and worldwide -- is free.  So why do only about half of thepopulation go through with it? The answer, suggests a new study in the journal Cancer Epidemiology, Biomarkers and Prevention, is something of a self-fulfilling prophecy:people believe if they're going to get cancer, they'll die from it anyway, so why bother? This attitude, known as cancer fatalism, is known to be a factor in African Americans' lower rates of colorectal cancer screening in the U.S.  It may also be a key reason people of lower socioeconomic status in the U.K. fail to follow through on testing, reported University of London Psychologist Anne Miles and colleagues.
September 1, 2011 | By Karen Kaplan, Los Angeles Times/For the Booster Shots blog
Firefighters who rushed to the World Trade Center on Sept. 11, 2001, and those who worked at the site in the weeks and months after the terrorist attack continue to live with an increased risk of cancer, according to a new study in the journal Lancet. The incidence of cancer in firefighters who worked at ground zero was 32% higher than in firefighters who did not spend time in Lower Manhattan. After adjusting for the fact that doctors spent more time examining the health of rescue workers after 9/11, researchers still found that firefighters who worked at the trade center site were 19% more likely than their counterparts to develop any kind of cancer.
August 18, 2011
When Katy Perry first came on the scene, some dismissed her as a one-hit wonder. Three years later, she has proved she's a multi-hit wonder, becoming the first woman to score five No. 1 songs from one album on the Billboard Hot 100 chart. Her "Last Friday Night (T.G.I.F.)" set the precedent: It's the latest No. 1 from her platinum album "Teenage Dream. " Only Michael Jackson had five No. 1s from one album ("Bad") before Perry. But Jackson spent a total of seven weeks at the top with his "Bad" songs; Perry has been at the top perch now for a cumulative 18 weeks.
June 13, 2011 | Marc Siegel, The Unreal World
The premise Joe (Ray Romano) and Manfro (Jon Manfrellotti) are good friends who go to a strip club the night before Manfro is scheduled to begin chemotherapy to treat Stage 3 colon cancer. Manfro, whose tumor had spread to his lymph nodes by the time it was detected in a colonoscopy screening exam, has already had surgery to remove the bulk of his tumor. At the club, he meets a stripper whose father also has Stage 3 colon cancer and went to the same oncologist that is treating Manfro.
Los Angeles Times Articles